Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Myopathy, Idiopathic”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07668505
What this trial is testing

Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies

Who this might be right for
Myositis
Chinese University of Hong Kong 10
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Not applicableUnknownNCT01702870
What this trial is testing

Diagnostic Accuracy of MR in Myositis

Who this might be right for
MyositisMuscular Disorders, Atrophic
University of Warwick 70
Large-scale testing (Phase 3)Study completedNCT03267277
What this trial is testing

Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis

Who this might be right for
DermatomyositisIdiopathic Inflammatory Myopathies
National Institute of Environmental Health Sciences (NIEHS) 15
Very early researchNot Yet RecruitingNCT06970951
What this trial is testing

Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisDry Syndrome+2 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 15
Not applicableStudy completedNCT01697254
What this trial is testing

The CARRA Registry

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusMixed Connective Tissue Disease+9 more
Duke University 9,587
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Not applicableStudy completedNCT00341679
What this trial is testing

Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases

Who this might be right for
Autoimmune/Connective Tissue DiseasesIdiopathic Inflammatory MyopathiesPolymyositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 719
Very early researchWithdrawnNCT06866080
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Large-scale testing (Phase 3)Looking for participantsNCT06698796
What this trial is testing

Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

Who this might be right for
DermatomyositisPolymyositis
Pfizer 211
Early research (Phase 1)UnknownNCT06316076
What this trial is testing

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory Myopathies+1 more
RenJi Hospital 48
Early research (Phase 1)Not Yet RecruitingNCT07544225
What this trial is testing

Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Sjogren's Disease With Dry Eyes+2 more
Gustave Roussy, Cancer Campus, Grand Paris 6
Early research (Phase 1)Looking for participantsNCT07184450
What this trial is testing

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Who this might be right for
Juvenile Dermatomyositis (JDM)Polyarticular Juvenile Idiopathic ArthritisSystemic Sclerosis (SSc)+1 more
Chongqing Precision Biotech Co., Ltd 11
Large-scale testing (Phase 3)Study completedNCT01862926
What this trial is testing

Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Inflammatory Myositis+1 more
Royal Brompton & Harefield NHS Foundation Trust 104
Post-approval studies (Phase 4)UnknownNCT01151644
What this trial is testing

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisSystemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo 5,000
Not applicableStudy completedNCT04486261
What this trial is testing

High-intensity Strength Training in Myositis

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
Rigshospitalet, Denmark 34
Testing effectiveness (Phase 2)Ended earlyNCT05000216
What this trial is testing

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris+6 more
National Institute of Allergy and Infectious Diseases (NIAID) 258
Not applicableLooking for participantsNCT00017914
What this trial is testing

Adult and Juvenile Myositis

Who this might be right for
DermatomyositisPolymyositisInclusion Body Myositis
National Institute of Environmental Health Sciences (NIEHS) 1,200
Testing effectiveness (Phase 2)Study completedNCT04208464
What this trial is testing

JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM

Who this might be right for
Idiopathic Inflammatory Myopathies
University of Manchester 15
Next Page